Comprehensive treatment of stage-lllb testicular non-seminomatous germ cell tumor: a case report and review of the literature / 中华男科学杂志
National Journal of Andrology
;
(12): 263-266, 2014.
Article
in Chinese
| WPRIM
| ID: wpr-309723
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the comprehensive treatment of stage-IIIb testicular non-seminomatous germ cell tumor (NSGCT) based on the chemotherapy with cisplatin, etoposide and bleomycin (BEP) and nerve-sparing laparoscopic retroperitoneal lymph node dissection (nsLRPLND).</p><p><b>METHODS</b>We reported a case of stage-IIIb testicular NSGCT, analyzed the clinical data and treatment methods and reviewed the relevant literature.</p><p><b>RESULTS</b>The patient underwent chemotherapy with etoposide (0. 18 g/d for the first 3 days), cisplatin (30 mg/d for the first 5 days), and bleomycin (30 mg/d on day 2, 9 and 16) for 3 cycles, followed by nsLRPLND. Both chemotherapy and surgery were successfully performed. The operation time was 175 min, with intraoperative blood loss of 50 ml, but no severe perioperative complications. No recurrence and distant metastasis were found during the 6-month follow-up after surgery.</p><p><b>CONCLUSION</b>The comprehensive treatment based on BEP chemotherapy and nsRPLND can be used as an option for stage-IIIb testicular NSGCT.</p>
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Testicular Neoplasms
/
Therapeutics
/
Antineoplastic Combined Chemotherapy Protocols
/
Retrospective Studies
/
Combined Modality Therapy
/
Therapeutic Uses
/
Lymph Node Excision
/
Methods
Type of study:
Observational study
Limits:
Adult
/
Humans
/
Male
Language:
Chinese
Journal:
National Journal of Andrology
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS